electroCore Inc. Common Stock (ECOR)
Stock · NASDAQ · Health Care
$7.99as of 10/16/2026
Price chart
Active signals
ECOR Signal Track Record
How signals performed across all stocks →What ECOR's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 39 | -0.4% | 49% | September 16, 2026 |
| Bollinger Band Breakout | 26 | -1.2% | 42% | September 17, 2026 |
| Bollinger Band Breakdown | 20 | +3.0% | 60% | June 24, 2026 |
| 200-Day Moving Average TouchActive now | 13 | +2.3% | 54% | July 22, 2026 |
| Any 20-session window (baseline) | +0.2% | 50% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About ECOR
electroCore, Inc., a bioelectronic technology medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as…
- Sector
- Health Care
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Employees
- 83
- Website
- www.electrocore.com/
Fundamentals
- 1-day range
- $7.35$8.42
- Market cap
- $60.41M
- P/E (trailing)
- —
- P/E (forward)
- -14.27
- EPS (trailing)
- $-1.66
- Dividend yield
- —
- Beta
- 1.14
- Avg. volume
- 83.8K
How electroCore Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 19, 2026 · via SEC EDGAR / Finnhub
Forecasts
5 analyst ratings
electroCore Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- ECORelectroCore Inc. Common Stock$7.85▼ 5.99%Market cap $60.41MP/E —$4.41$12.7
- POCIPrecision Optics Corporation Inc. Common stock$4.32▼ 0.69%Market cap $46.41MP/E —$3.55$6.15
- STEXStreamex Corp. Common Stock$0.374▼ 8.33%Market cap $75.35MP/E —$0.3876$6.5
- QTIQT Imaging Holdings Inc. Common Stock$2.4▲ 0.84%Market cap $37.38MP/E —$2.38$19.05
- NRXSNeuraxis Inc. Common Stock$7.7▼ 0.52%Market cap $86.47MP/E —$2.21$9.33
- OMOutset Medical Inc. Common Stock$3.94▼ 3.43%Market cap $96.39MP/E —$2.84$15.94
- HYPRHyperfine Inc. Class A Common Stock$0.755▼ 3.21%Market cap $97.48MP/E —$0.7536$2.22
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| ECOR electroCore Inc. Common Stock | $60.41M | — | $7.85 | ▼ 5.99% | $4.41$12.7 |
| POCI Precision Optics Corporation Inc. Common stock | $46.41M | — | $4.32 | ▼ 0.69% | $3.55$6.15 |
| STEX Streamex Corp. Common Stock | $75.35M | — | $0.374 | ▼ 8.33% | $0.3876$6.5 |
| QTI QT Imaging Holdings Inc. Common Stock | $37.38M | — | $2.4 | ▲ 0.84% | $2.38$19.05 |
| NRXS Neuraxis Inc. Common Stock | $86.47M | — | $7.7 | ▼ 0.52% | $2.21$9.33 |
| OM Outset Medical Inc. Common Stock | $96.39M | — | $3.94 | ▼ 3.43% | $2.84$15.94 |
| HYPR Hyperfine Inc. Class A Common Stock | $97.48M | — | $0.755 | ▼ 3.21% | $0.7536$2.22 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- electroCore Has A Line Of Sight At Cash BreakevenSeekingAlpha · 9/26/2026
- electroCore (ECOR) Stock Jumps 6.9%: Will It Continue to Soar?Yahoo · 9/18/2026
- Full Transcript: electroCore Q2 2026 Earnings Callbenzinga · 9/18/2026
- Full Transcript: electroCore Q2 2026 Earnings CallBenzinga · 9/18/2026
Insider Activity
Insider Actions →- Thomas J. Errico · September 14, 2026 · Buy5.0K @ $9.82
- Michael Fox · September 11, 2026 · Grant5.0K @ $9.8
- Michael Fox · September 11, 2026 · Buy5.0K @ $9.8
- Thomas J. Errico · September 9, 2026 · Grant15.6K
- James Charles Theofilos · September 9, 2026 · Grant11.1K
- Patricia Wilber · September 9, 2026 · Grant11.1K
- Elena Bonfiglioli · September 9, 2026 · Grant11.1K
- Julie Ann Goldstein · September 9, 2026 · Grant11.1K
- John P. Gandolfo · September 9, 2026 · Grant11.1K
- Michael Fox · September 8, 2026 · Grant55.0K
- Joshua S. Lev · September 8, 2026 · Grant55.0K
- Joshua S. Lev · August 25, 2026 · Option Exercise3.0K @ $4.5
- Joshua S. Lev · August 25, 2026 · Sale3.0K @ $9.36
- Joshua S. Lev · August 24, 2026 · Option Exercise5.0K @ $4.5
- Joshua S. Lev · August 24, 2026 · Sale5.0K @ $9.88
Institutional Ownership
March 31, 2026
- Total shares held
- 767.5K
- Total value held
- $4.65M
- Institutional holders
- 27
- Unknown202.6K
- Unknown116.5K
- Unknown78.1K
- Unknown58.2K
- Unknown47.5K
- Unknown46.6K
- Unknown44.4K
- Unknown35.3K
- Unknown26.8K
- Unknown26.5K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
ECOR Approaches Cash Breakeven, According to SeekingAlpha
SeekingAlpha reports that electroCore is now on a trajectory toward cash breakeven. The analysis suggests the company’s operating cash flow is improving, which could reduce financial risk. This development may influence how investors view the firm’s near‑term financial stability.
ECOR Approaches Cash Breakeven, According to SeekingAlpha. SeekingAlpha reports that electroCore is now on a trajectory toward cash breakeven. The analysis suggests the company’s operating cash flow is improving, which could reduce financial risk. This development may influence how investors view the firm’s near‑term financial stability.